| | | | | |
AGIO Agios Pharmaceuticals, Inc. | €24,8238 | +4,35% | €1,50B | €104,97K | |
SGRY Surgery Partners, Inc. Common Stock | €11,8812 | +2,33% | €1,50B | €279,56K | |
GAB The Gabelli Equity Trust Inc. | €4,8083 | -0,27% | €1,50B | €477,48K | |
HURN Huron Consulting Group Inc. | €92,5488 | +2,75% | €1,49B | €21,58K | |
ENVX Enovix Corporation Common Stock | €7,1347 | +0,88% | €1,49B | €2,36M | |
PAYO Payoneer Global Inc. Common Stock | €4,4732 | +2,26% | €1,49B | €952,78K | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | €12,8222 | +0,07% | €1,49B | €57,05K | |
STGW Stagwell Inc. Class A Common Stock | €5,8482 | +3,26% | €1,49B | €178,72K | |
CASH Pathward Financial, Inc. Common Stock | €67,7869 | +1,46% | €1,49B | €47,56K | |
SNDX Syndax Pharmaceuticals, Inc. | €15,4305 | -2,10% | €1,49B | €3,58M | |
STRA Strategic Education, Inc. Common Stock | €70,0712 | +3,14% | €1,49B | €58,20K | |
CAPR Capricor Therapeutics Inc | €24,3038 | +2,32% | €1,49B | €141,08K | |
AAPG Ascentage Pharma Group International American Depository Shares | €15,8293 | +3,07% | €1,48B | €1,48K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | €7,6186 | +8,24% | €1,48B | €3,00M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | €23,6722 | +10,22% | €1,48B | €240,51K | |
